Proceedings of the 2nd BEAT-PCD conference and 3rd PCD training school: Part 1

TY - JOUR

T1 - Proceedings of the 2nd BEAT-PCD conference and 3rd PCD training school

T2 - 2nd BEAT-PCD Conference

AU - Halbeisen, Florian

AU - Hogg, Claire

AU - Alanin, Mikkel C.

AU - Bukowy-Bieryllo, Zuzanna

AU - Dasi, Francisco

AU - Duncan, Julie

AU - Friend, Amanda

AU - Goutaki, Myrofora

AU - Jackson, Claire

AU - Keenan, Victoria

AU - Harris, Amanda

AU - Hirst, Robert A.

AU - Latzin, Philipp

AU - Marsh, Gemma

AU - Nielsen, Kim

AU - Norris, Dominic

AU - Pellicer, Daniel

AU - Reula, Ana

AU - Rubbo, Bruna

AU - Rumman, Nisreen

AU - Shoemark, Amelia

AU - Walker, Woolf T.

AU - Kuehni, Claudia E.

AU - Lucas, Jane S.

PY - 2018

Y1 - 2018

N2 - Primary ciliary dyskinesia (PCD) is a rare heterogenous condition that causes progressive suppurative lung disease, chronic rhinosinusitis, chronic otitis media, infertility and abnormal situs. 'Better Experimental Approaches to Treat Primary Ciliary Dyskinesia' (BEAT-PCD) is a network of scientists and clinicians coordinating research from basic science through to clinical care with the intention of developing treatments and diagnostics that lead to improved long-term outcomes for patients. BEAT-PCD activities are supported by EU funded COST Action (BM1407). The second BEAT-PCD conference, and third PCD training school were held jointly in April 2017 in Valencia, Spain. Presentations and workshops focussed on advancing the knowledge and skills relating to PCD in: basic science, epidemiology, diagnostic testing, clinical management and clinical trials. The multidisciplinary conference provided an interactive platform for exchanging ideas through a program of lectures, poster presentations, breakout sessions and workshops. Three working groups met to plan consensus statements. Progress with BEAT-PCD projects was shared and new collaborations were fostered. In this report, we summarize the meeting, highlighting developments made during the meeting.

AB - Primary ciliary dyskinesia (PCD) is a rare heterogenous condition that causes progressive suppurative lung disease, chronic rhinosinusitis, chronic otitis media, infertility and abnormal situs. 'Better Experimental Approaches to Treat Primary Ciliary Dyskinesia' (BEAT-PCD) is a network of scientists and clinicians coordinating research from basic science through to clinical care with the intention of developing treatments and diagnostics that lead to improved long-term outcomes for patients. BEAT-PCD activities are supported by EU funded COST Action (BM1407). The second BEAT-PCD conference, and third PCD training school were held jointly in April 2017 in Valencia, Spain. Presentations and workshops focussed on advancing the knowledge and skills relating to PCD in: basic science, epidemiology, diagnostic testing, clinical management and clinical trials. The multidisciplinary conference provided an interactive platform for exchanging ideas through a program of lectures, poster presentations, breakout sessions and workshops. Three working groups met to plan consensus statements. Progress with BEAT-PCD projects was shared and new collaborations were fostered. In this report, we summarize the meeting, highlighting developments made during the meeting.

U2 - 10.1186/s12919-018-0098-9

DO - 10.1186/s12919-018-0098-9

M3 - Comment/debate

C2 - 29630684

AN - SCOPUS:85042920184

SN - 1753-6561

VL - 12

JO - B M C Proceedings

JF - B M C Proceedings

IS - Suppl. 2

M1 - 1

Y2 - 18 April 2017 through 21 April 2017

ER -